Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | DRD3 | P35462 | 12/20 | 0.56 |
| ▸ | DRD2 | P14416 | 11/20 | 0.56 |
| ▸ | DRD4 | P21917 | 7/20 | 0.56 |
| ▸ | HTR1A | P08908 | 6/20 | 0.56 |
| ▸ | HTR2B | P41595 | 6/20 | 0.56 |
| ▸ | HTR2A | P28223 | 8/20 | 0.55 |
| ▸ | HTR2C | P28335 | 4/20 | 0.55 |
| ▸ | DRD1 | P21728 | 3/20 | 0.55 |
| ▸ | CACNA1G | O43497 | 2/20 | 0.47 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4490269 | 1.00 | DRD3 (0.56) | DRD3DRD2DRD4HTR1AHTR2B | |
| SCHEMBL13630349 | 0.91 | DRD2 (0.57) | DRD3DRD2DRD4HTR1AHTR2B | |
| SCHEMBL4493260 | 0.91 | DRD2 (0.57) | DRD3DRD2DRD4HTR1AHTR2B | |
| SCHEMBL13630022 | 0.90 | DRD3 (0.57) | DRD3DRD2DRD4HTR1AHTR2B | |
| SCHEMBL4492199 | 0.90 | DRD3 (0.57) | DRD3DRD2DRD4HTR1AHTR2B | |
| SCHEMBL4481120 | 0.89 | DRD3 (0.54) | DRD3DRD2DRD4HTR1AHTR2B | |
| SCHEMBL13630108 | 0.89 | DRD3 (0.54) | DRD3DRD2DRD4HTR1AHTR2B | |
| SCHEMBL13630215 | 0.89 | DRD3 (0.55) | DRD3DRD2DRD4HTR1AHTR2B | |
| SCHEMBL4490471 | 0.89 | DRD3 (0.55) | DRD3DRD2DRD4HTR1AHTR2B | |
| SCHEMBL4502219 | 0.89 | DRD2 (0.57) | DRD3DRD2DRD4HTR1AHTR2B |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20090286801-A1 | CARBONYLATED (AZA) CYCLOHEXANES AS DOPAMINE D3 RECEPTOR LIGANDS | BIOPROJET (FR) | 2009-11-19 | — | — | US | disclosed |
| US-20090286801-A1 | CARBONYLATED (AZA) CYCLOHEXANES AS DOPAMINE D3 RECEPTOR LIGANDS | BIOPROJET (FR) | 2009-11-19 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090286801-A1 | CARBONYLATED (AZA) CYCLOHEXANES AS DOPAMINE D3 RECEPTOR LIGANDS | DRD3, TACR2, TACR1 | DRD3 1/4885DRD2 4/4885DRD4 8/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.